FFRct vs AI-ECG Tracker
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
HeartFlow FFRct is designed for non-invasive diagnosis of coronary artery disease by analyzing CCTA scans to assess coronary blood flow. In contrast, the AI-ECG Tracker provides rapid, AI-powered auto-analysis of 12-lead ECG data for a wide range of cardiac abnormalities. While both are cardiology AI tools, they address distinct diagnostic needs using different data modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that assesses blood flow in coronary arteries from CCTA scans to aid in diagnosing coronary artery disease (CAD) and guiding treatment strategies. In contrast, the AI-ECG Tracker provides AI-powered auto-analysis and diagnosis of 12-lead ECG data for various cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
HeartFlow FFRct Analysis requires previously acquired Coronary CT Angiography (CCTA) scans to generate personalized 3D models of coronary arteries for blood flow analysis. The AI-ECG Tracker utilizes 12-lead ECG data for its AI-powered auto-analysis and diagnosis.
HeartFlow FFRct Analysis generates personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing (FFRct values) to aid in diagnosing CAD and guiding treatment strategies. The AI-ECG Tracker offers rapid, comprehensive AI-powered auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications, with over 95% accuracy for common cardiac abnormalities.
HeartFlow FFRct Analysis is FDA cleared, HIPAA compliant, and has a Business Associate Agreement (BAA). The AI-ECG Tracker is also FDA cleared, and is likely HIPAA compliant and has a BAA, given the company's operations in the US healthcare market and general privacy practices.
The provided information for HeartFlow FFRct Analysis describes the analysis process but does not specify a typical turnaround time for results. In contrast, the AI-ECG Tracker provides a rapid diagnosis in approximately 3 seconds for its AI-ECG auto-analysis.